328 related articles for article (PubMed ID: 27216187)
1. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
[TBL] [Abstract][Full Text] [Related]
2. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
4. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram.
Cong J; Wang Y; Zhang X; Zhang N; Liu L; Soukup K; Michelakos T; Hong T; DeLeo A; Cai L; Sabbatino F; Ferrone S; Lee H; Levina V; Fuchs B; Tanabe K; Lillemoe K; Ferrone C; Wang X
Cancer Lett; 2017 Nov; 409():9-19. PubMed ID: 28864067
[TBL] [Abstract][Full Text] [Related]
5. Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell MB
Cell Biochem Biophys; 2017 Dec; 75(3-4):311-317. PubMed ID: 28429253
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell M
Interface Focus; 2017 Apr; 7(2):20160109. PubMed ID: 28382202
[TBL] [Abstract][Full Text] [Related]
7. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
Kisfalvi K; Eibl G; Sinnett-Smith J; Rozengurt E
Cancer Res; 2009 Aug; 69(16):6539-45. PubMed ID: 19679549
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer.
Boukalova S; Stursa J; Werner L; Ezrova Z; Cerny J; Bezawork-Geleta A; Pecinova A; Dong L; Drahota Z; Neuzil J
Mol Cancer Ther; 2016 Dec; 15(12):2875-2886. PubMed ID: 27765848
[TBL] [Abstract][Full Text] [Related]
10. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.
Langdon CG; Platt JT; Means RE; Iyidogan P; Mamillapalli R; Klein M; Held MA; Lee JW; Koo JS; Hatzis C; Hochster HS; Stern DF
Mol Cancer Ther; 2017 Jun; 16(6):1041-1053. PubMed ID: 28292938
[TBL] [Abstract][Full Text] [Related]
13. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies.
Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C
J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091
[TBL] [Abstract][Full Text] [Related]
14. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.
Akasaka H; Mizushina Y; Yoshida K; Ejima Y; Mukumoto N; Wang T; Inubushi S; Nakayama M; Wakahara Y; Sasaki R
Radiat Oncol; 2016 Nov; 11(1):153. PubMed ID: 27876069
[TBL] [Abstract][Full Text] [Related]
15. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells.
Hehlgans S; Eke I; Storch K; Haase M; Baretton GB; Cordes N
Radiother Oncol; 2009 Sep; 92(3):362-70. PubMed ID: 19665245
[TBL] [Abstract][Full Text] [Related]
17. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
18. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
[TBL] [Abstract][Full Text] [Related]
20. Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
Yamana H; Kato K; Kobara H; Fujihara S; Fujita K; Namima D; Fujita N; Kobayashi K; Kamada H; Morishita A; Tsutsui K; Iwama H; Masaki T
Anticancer Res; 2020 Jan; 40(1):121-132. PubMed ID: 31892560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
